Acp Iv, L.p. - Net Worth and Insider Trading
Acp Iv, L.p. Net Worth
The estimated net worth of Acp Iv, L.p. is at least $55 Million dollars as of 2024-11-10. Acp Iv, L.p. is the 10% Owner of Aerie Pharmaceuticals Inc and owns about 3,616,099 shares of Aerie Pharmaceuticals Inc (AERI) stock worth over $55 Million. Acp Iv, L.p. is also the 10% Owner of Talphera Inc and owns about 0 shares of Talphera Inc (TLPH) stock worth over $0. Details can be seen in Acp Iv, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Acp Iv, L.p. has not made any transactions after 2014-05-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Acp Iv, L.p.
Acp Iv, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Acp Iv, L.p. owns 3 companies in total, including KalVista Pharmaceuticals Inc (KALV) , Aerie Pharmaceuticals Inc (AERI) , and Talphera Inc (TLPH) .
Click here to see the complete history of Acp Iv, L.p.’s form 4 insider trades.
Insider Ownership Summary of Acp Iv, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2015-04-08 | 10 percent owner |
| AERI | Aerie Pharmaceuticals Inc | 2014-05-22 | 10 percent owner |
| TLPH | Talphera Inc | 2011-02-16 | 10 percent owner |
Acp Iv, L.p. Latest Holdings Summary
Acp Iv, L.p. currently owns a total of 2 stocks. Among these stocks, Acp Iv, L.p. owns 3,616,099 shares of Aerie Pharmaceuticals Inc (AERI) as of May 22, 2014, with a value of $55 Million and a weighting of 100%. Acp Iv, L.p. also owns 0 shares of Talphera Inc (TLPH) as of February 16, 2011, with a value of $0 and a weighting of 0%.
Latest Holdings of Acp Iv, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AERI | Aerie Pharmaceuticals Inc | 2014-05-22 | 3,616,099 | 15.25 | 55,145,510 |
| TLPH | Talphera Inc | 2011-02-16 | 0 | 0.91 | 0 |
Holding Weightings of Acp Iv, L.p.
Acp Iv, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Acp Iv, L.p. has made a total of 0 transactions in Aerie Pharmaceuticals Inc (AERI) over the past 5 years. The most-recent trade in Aerie Pharmaceuticals Inc is the sale of 300,000 shares on May 22, 2014, which brought Acp Iv, L.p. around $5 Million.
According to the SEC Form 4 filings, Acp Iv, L.p. has made a total of 0 transactions in Talphera Inc (TLPH) over the past 5 years. The most-recent trade in Talphera Inc is the acquisition of 34,000 shares on February 16, 2011, which cost Acp Iv, L.p. around $3 Million.
Insider Trading History of Acp Iv, L.p.
- 1
Acp Iv, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Acp Iv, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Acp Iv, L.p. is 29.15%. GuruFocus also compares Acp Iv, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Acp Iv, L.p. within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Acp Iv, L.p.'s insider trading performs compared to the benchmark.
Performance of Acp Iv, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.53 | | | | | |
| Relative Return to S&P 500(%) | -2.76 | | | | | |
Acp Iv, L.p. Ownership Network
Ownership Network List of Acp Iv, L.p.
Ownership Network Relation of Acp Iv, L.p.
Acp Iv, L.p. Owned Company Details
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
Acp Iv, L.p. is the 10 percent owner of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include CFO and Secretary Benjamin L Palleiko , Chief Medical Officer Paul K. Audhya , and Chief Development Officer Christopher Yea .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, Acp Iv, L.p. made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 144,760 shares made by Benjamin L Palleiko , and a net sale of 116,267 shares made by Edward P. Feener .
In summary, during the past 3 months, insiders sold 40,693 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 40,693 shares. During the past 18 months, 583,370 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 667,647 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
Acp Iv, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Acp Iv, L.p.. You might contact Acp Iv, L.p. via mailing address: One Embarcadero Center, Suite 3700, San Francisco Ca 94111.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
